SCHEDULE 13G

Kyverna Therapeutics, Inc.

Common Stock, par value $0.00001 per share · CUSIP: 501976104

Event date: 2025-11-13

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• GordonMD Global Investments LP

  Shares: 3,058,485.00 · Class: 7.0%

• GordonMD Long Biased Master Fund LP

  Shares: 2,735,783.00 · Class: 6.2%

• GordonMD Long Biased GP LLC

  Shares: 2,735,783.00 · Class: 6.2%

• Craig D. Gordon

  Shares: 3,058,485.00 · Class: 7.0%

• GordonMD Global Investments GP LLC

  Shares: 3,058,485.00 · Class: 7.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.